Table 1.
Demographic, clinical and pathological characteristics of the patients with stage I cervical cancer who underwent radical hysterectomy and tested positive for HPV types 16 and 18.
| Characteristics | HPV 16* | HPV 18* | ||
| n | % | n | % | |
| Age (years) | ||||
| Median | 39 | 39 | ||
| Range | 9.27 | 8.77 | ||
| ≤30 | 5 | 9.3 | 3 | 11.5 |
| 30–50 | 39 | 72.2 | 19 | 73.1 |
| >50 | 10 | 18.5 | 4 | 15.4 |
| Clinical stage (FIGO) | ||||
| IB1 | 46 | 85.2 | 22 | 84.6 |
| IB2 | 8 | 14.8 | 4 | 15.4 |
| Histological type | ||||
| Squamous cell carcinoma | 46 | 85.2 | 22 | 84.6 |
| Adenocarcinoma | 5 | 9.3 | 2 | 7.7 |
| Adenosquamous cell carcinoma | 3 | 5.6 | 2 | 7.7 |
| Others | 0 | 0 | 0 | 0 |
| Grade of differentiation | ||||
| Grade I | 1 | 2 | 1 | 4.2 |
| Grade II | 33 | 66 | 17 | 70.8 |
| Grade III | 16 | 32 | 6 | 25 |
| Metastases to lymph nodes | ||||
| Yes | 3 | 5.6 | 3 | 12 |
| No | 51 | 94.4 | 22 | 88 |
| Angiolymphatic invasion | ||||
| Yes | 12 | 28.6 | 5 | 25 |
| No | 30 | 71.4 | 75 | 75 |
| Initial treatment | ||||
| Surgery alone | 42 | 77.8 | 20 | 76.9 |
| Surgery + radiotherapy | 9 | 16.7 | 4 | 15.4 |
| Radiotherapy + surgery | 3 | 5.6 | 2 | 7.7 |
| Recurrence of the disease | ||||
| Yes | 5 | 9.8 | 3 | 12 |
| No | 46 | 90.2 | 22 | 88 |
| Treatment of recurrence | ||||
| Radiotherapy | 0 | 0 | 0 | 0 |
| Chemotherapy | 1 | 100 | 1 | 100 |
| Radiotherapy + chemotherapy | 0 | 0 | 0 | 0 |
*
HPV-positive patients.